Key Stats | |
---|---|
Open | $764.77 |
Prev. Close | $763.97 |
EPS | 6.76 |
Dividend | $4.86 |
Next Earnings Date | Sep 12, 2024 |
Dividend Yield % | 0.68% |
Market Cap | $722.30B |
PE Ratio | 114.49 |
LOW | HIGH | |
---|---|---|
Day Range | 763.34 | 777.45 |
52 Week Range | 419.79 | 800.78 |
Ratios | |
---|---|
P/B Ratio | 66.34 |
Revenue | $34.12B |
Operating M. % | 31.20% |
Earnings | $5.24B |
Earnings Growth % | -16.08% |
EBITDA Margin % | 39.19% |
ROEÂ % | 50.75% |
EPS | 6.76 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
All Score 75 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
LLY | MARKET | |
---|---|---|
Value | 22 | 38 |
Quality | 69 | 40 |
Ownership | 43 | 17 |
Growth | 84 | 46 |
Dividends | 38 | 37 |
Eli Lilly & Co's Price growth average in the last 3 years of 57.36% is great compared to market average of 7.74%. This indicates LLY could be a good value stock.
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
The current price per share for Eli Lilly & Co (LLY) is $773.95. The stock has seen a price change of $9.97 recently, indicating a 1.31% change. This reflects the stock's recent market performance and investor sentiment.
For Eli Lilly & Co (LLY), the 52-week high is $800.78, which is 3.47% from the current price. The 52-week low is $419.8, the current price is 84.36% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Eli Lilly & Co (LLY) has shown an average price growth of 0.41% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Eli Lilly & Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
As of the latest data, Eli Lilly & Co (LLY) has a year-to-date price change of 30.69%. Over the past month, the stock has experienced a price change of 3.09%. Over the last three months, the change has been 2.2%. Over the past six months, the figure is 26.71%. Looking at a longer horizon, the five-year price change stands at 573.35%.
Eli Lilly & Co (LLY) has a net income of $5.24B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 80.73% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 31.2% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $34.12B, with a revenue growth rate of 19.56%, providing insight into the company's sales performance and growth. The gross profit is $27.55B. Operating income is noted at $10.33B. Furthermore, the EBITDA is $13.55B.
Eli Lilly & Co (LLY) has a market capitalization of $722.31B. The average daily trading volume is 2.47M, indicating the stock's liquidity and investor engagement.
Boeing’s Aircraft Deliveries to North America Hit 22-Year High at 293 Units
NYCB to Boost Capital and Liquidity Through $5 Billion Loan Sale to JPMorgan Chase
Gemini Ultra Training Costs in 2023 Neared $200 Million, More Than 2X GPT4
Microsoft Leads in Carbon Dioxide Removal (CDR) Credit Purchases, Acquiring 6.6M Tonnes, Surpassing All Other Buyers Combined
SoftBank’s Profitability Surges Amid AI Investment Boom
Revolut Hit 26 Million Downloads in 2023, 65% more than a Year Before
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.